All Videos

An expert rheumatologist and a dermatologist discuss challenges to bringing biosimilars to the United States.

Drs Sherrif F. Ibrahim and Vishal Patel discuss the importance of a multidisciplinary team in the treatment of BCC as well as best practices for preventing advanced BCC.

Sherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, provide an overview of BCC and discuss disease burden.

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses what patients need to know about oral minoxidil for hair loss.

Dr Chen Discusses epidemiology and racial disparities in CTCL.

Drs Joshua Zeichner, MD, and Mona Gohara, MD, provide take-home messages to providers treating patients with acne.

Expert dermatologists discuss different types of moisturizers and how to properly select a moisturizer.

Deucravacitinib offers new hope for those with moderate-to-severe plaque psoriasis.

Hilary Baldwin, MD, discusses what's new and exciting at the Skin of Color Update Meeting in NYC

Expert rheumatologist and dermatologist, Drs Roy M. Fleischmann and Joel M. Gelfand, discuss the impact of switching patients to biosimilars.

Drs Roy M. Fleischmann and Joel M. Gelfand discuss the roles of biosimilars and how to assess efficacy once a patient is switched to a biosimilar.

Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, provide take-home messages for dermatologists treating pediatric patients with atopic dermatitis.

Atopic dermatitis specialists discuss how to have a conversation with parents about risks of biologics and how to answer questions about length of therapy.

Expert pediatric dermatologists provide impressions on the case of a 12-year-old girl with atopic dermatitis.

Joshua Zeichner, MD, reviews the case of a 12-year-old girl with atopic dermatitis.

TMB-001 showed positive results in the reduction of congenital ichthyosis severity in a phase 2b CONTROL study.

DaxibotulinumtoxinA for Injection will provide long-lasting results with fewer injection treatments over time.

Joshua Zeichner, MD, and Mona Gohara, MD, discuss what ingredients make an ideal moisturizer.

Joshua Zeichner, MD, and Mona Gohara, MD, discuss different types of lipid-free cleansers and how to properly select a cleanser.

Roy M. Fleischmann, MD, and Joel M. Gelfand, MD, MSCE, FAAD, discuss the impact of biosimilars on payers, health care systems, and patients.

Expert rheumatologist and dermatologist, Drs Roy M. Fleischmann and Joel M. Gelfand discuss unmet needs in biosimilars.

Drs Roy M. Fleischmann and Joel M. Gelfand define interchangeability status and discuss its impact on the field of dermatology and rheumatology.

Expert pediatric dermatologists discuss the importance of combination therapy and shared decision-making when treating pediatric patients with atopic dermatitis.

Brittany Craiglow, MD, and Joshua Zeichner, MD, discuss treatment adherence in pediatric patients with atopic dermatitis.

Vikash Oza, MD, provides clinical insight for Case 2, a 7-year-old female patient with atopic dermatitis.

Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; and Vikash Oza, MD, address techniques for injectables when treating pediatric patients with atopic dermatitis.

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses how to treat tinea versicolor.

Dr Joshua Zeichner reviews the case of a 7-year-old female patient with atopic dermatitis.

Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, discuss treatments beyond topical agents and the use of dupilumab in pediatric patients with atopic dermatitis.

Expert pediatric dermatologists Drs Elizabeth Swanson, Joshua Zeichner, and Raj Chovatiya share impressions from patient case No. 1.